Amarin Corp Plc (AMRN)

[couldbebetter]

rosemountbomber, You make many excellent points.
One risk to a GIA strategy is that in time a better
medication may come along, or even one that could
be more cost effective. Not likely anytime soon,
but still a longer term concern.

I hope Vascepa reduces the risk of Alzheimer's, but proving
it may be a battle to large for AMRN to undertake. Plus, there
may be medications that may prove more beneficial. AVXL has a
number of compounds that look promising but proving it may be
very long road for them. There will be others that are in the
works that look promising, but still a long ways off.